CTOs on the Move

Equipment Planning Associates Limited

www.epaepa.ca

 
Equipment Planning Associates Limited is a Richmond Hill, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million
  • www.epaepa.ca
  • Ste 202 70 E Beaver Creek Rd
    Richmond Hill, ON CAN L4B 3B2
  • Phone: 905.771.9733

Executives

Name Title Contact Details

Similar Companies

Angelini Pharma

Angelini Pharma is a Gaithersburg, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ophthonix

Ophthonix is a Vista, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Shockwave Medical

Shockwave Medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. Inspired by 30-years of safety and efficacy in kidney stone treatment, our Intravascular Lithotrispy family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. IVL catheters use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. An integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. In peripheral vascular clinical study of moderate and severely calcified lesions in 95 patients, IVL demonstrated safety and consistent procedure success with low procedural complications. The technology is inherently familiar, easy to use, operates with just the push of a button, and works with existing cardiovascular treatments. And because it is built on a traditional balloon catheter platform, it integrates seamlessly with clinicians` existing workflow.

Covalent Medical Inc

Covalent Medical Inc is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Astellas Gene Therapies

Astellas Gene Therapies is an Astellas Center of Excellence developing genetic medicines with the potential to deliver transformative value for patients. Based on an innovative scientific approach and industry leading internal manufacturing capability and expertise, we are currently exploring three gene therapy modalities: gene replacement, exon skipping gene therapy, and vectorized RNA knockdown and will also advance additional Astellas gene therapy programs toward clinical investigation. We are based in San Francisco, with manufacturing and laboratory facilities in South San Francisco and Sanford, North Carolina.